Acuitas Investments LLC Purchases 159,743 Shares of Uranium Royalty Corp. $UROY

Acuitas Investments LLC boosted its holdings in Uranium Royalty Corp. (NASDAQ:UROY) by 15.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,172,719 shares of the company’s stock after buying an additional 159,743 shares during the quarter. Uranium Royalty makes up about 3.2% of Acuitas Investments LLC’s holdings, making the stock its 10th largest position. Acuitas Investments LLC owned 0.85% of Uranium Royalty worth $5,043,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Goldman Sachs Group Inc. boosted its position in shares of Uranium Royalty by 25.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 104,243 shares of the company’s stock worth $183,000 after acquiring an additional 21,118 shares in the last quarter. Thompson Davis & CO. Inc. purchased a new stake in Uranium Royalty during the second quarter worth approximately $33,000. Accordant Advisory Group Inc boosted its holdings in Uranium Royalty by 4.6% in the second quarter. Accordant Advisory Group Inc now owns 2,441,702 shares of the company’s stock valued at $6,104,000 after purchasing an additional 107,216 shares in the last quarter. Vident Advisory LLC boosted its holdings in Uranium Royalty by 47.1% in the second quarter. Vident Advisory LLC now owns 1,480,151 shares of the company’s stock valued at $3,700,000 after purchasing an additional 474,030 shares in the last quarter. Finally, Corient Private Wealth LLC purchased a new position in Uranium Royalty in the second quarter valued at approximately $29,000. 24.19% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts recently commented on UROY shares. Zacks Research downgraded shares of Uranium Royalty from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 26th. Weiss Ratings upgraded shares of Uranium Royalty from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, March 12th. Finally, Raymond James Financial reissued a “market perform” rating on shares of Uranium Royalty in a research note on Wednesday, January 14th. One investment analyst has rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $4.50.

Uranium Royalty Stock Up 1.1%

NASDAQ:UROY opened at $3.71 on Wednesday. The stock has a fifty day simple moving average of $4.23 and a 200 day simple moving average of $3.98. The firm has a market capitalization of $543.44 million, a price-to-earnings ratio of 185.59 and a beta of 1.46. Uranium Royalty Corp. has a 1-year low of $1.43 and a 1-year high of $5.52.

Uranium Royalty (NASDAQ:UROY) last issued its quarterly earnings results on Tuesday, March 10th. The company reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.01) by $0.02. Uranium Royalty had a net margin of 7.70% and a return on equity of 0.01%. The business had revenue of $12.25 million during the quarter. Equities analysts predict that Uranium Royalty Corp. will post 0.01 earnings per share for the current year.

Uranium Royalty Profile

Uranium Royalty Corp. is a Vancouver-based mineral rights acquisition, royalty and streaming company focused exclusively on the uranium sector. Established in early 2021 and listed on the NASDAQ under the symbol UROY, the company seeks to provide investors with leveraged exposure to uranium prices without direct mining risk. Rather than owning or operating mines, Uranium Royalty acquires long-term royalties and streams on both production and development-stage uranium projects worldwide.

The company’s diversified portfolio encompasses royalty interests across multiple jurisdictions, including Canada, the United States, South America, Central Asia and Australia.